Short Interest in Avalon GloboCare Corp. (NASDAQ:ALBT) Rises By 28.9%

Avalon GloboCare Corp. (NASDAQ:ALBT) was the recipient of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 32,100 shares, a growth of 28.9% from the March 31st total of 24,900 shares. Based on an average trading volume of 78,100 shares, the short-interest ratio is currently 0.4 days. Approximately 5.0% of the company’s shares are sold short.

Avalon GloboCare Stock Performance

Shares of NASDAQ:ALBT opened at $3.55 on Friday. Avalon GloboCare has a 52 week low of $2.11 and a 52 week high of $21.60. The firm has a market cap of $5.86 million, a PE ratio of -0.18 and a beta of 0.16. The firm’s fifty day moving average is $5.18 and its 200-day moving average is $4.04.

Avalon GloboCare Company Profile

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.